Celeste Wilcox, M.D., Ph.D.

Celeste A Wilcox, MD - Texas Oncology PA, located in Idabel, OK, is part of The US Oncology Network, which provides over 25 years of oncology practice management expertise. The organization is dedicated to enhancing cancer care through innovative clinical trials and a commitment to patient-centric services, supported by the extensive resources of McKesson. With a network of 600 sites of care and 2,700 affiliated providers, Texas Oncology strives to empower independent practices by offering access to capital, best business practices, and critical support for physicians. The organization plays an integral role in shaping the future of cancer treatment and maintains a strong focus on improving physician and patient satisfaction. Generated from the website

Celeste A Wilcox, MD at Texas Oncology in Paris, TX, is part of The US Oncology Network, which provides over 25 years of expertise in oncology practice management. With a commitment to patient-centered care, the network supports independent oncology practices through access to resources, innovative clinical trials, and the backing of McKesson, a trusted leader in healthcare for more than 180 years. Dedicated to excellence in cancer care, The US Oncology Network treats approximately 1.4 million patients each year across 600 sites of care, with 70% of its physicians engaged in advancing treatment through the Enhancing Oncology Model. The network fosters collaboration and growth within community practices, ensuring they can maintain their independence while benefiting from best business practices and clinical innovation. Generated from the website

Texas Oncology is a comprehensive cancer care provider with a wide range of services and treatments for cancer and blood disorders. From cancer prevention and screening to advanced therapies like CAR-T and precision medicine, Texas Oncology offers specialized care through a network of providers across various regions in Texas. The organization also focuses on patient support services, genetic risk evaluation, and clinical trials, emphasizing a patient-centered approach to cancer treatment. With a commitment to advancing cancer research and providing quality care, Texas Oncology is dedicated to helping Texans fight cancer.Generated from the website